Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Cataract and Refractive Surgery|November 4, 2006
Secondary prosthetic iris implantation following traumatic total aniridia and pseudophakiaFaruk Ozturk, Robert H Osher, James M OsherClinical Ophthalmology (Auckland, N.Z.)|August 25, 2015
Preretinal hemorrhage as a presenting sign of idiopathic macular telangiectasia type 2James M Osher, Robert A Sisk, Michael R PetersenJournal of Cataract and Refractive Surgery|February 2, 2010
Multifocal iris sphincter ruptures: new sign of the lens-iris diaphragm retropulsion syndromeRobert H Osher, James M Osher, Robert J CionniJAMA Ophthalmology|May 1, 2018
Association of Mentor-to-Program Contact and Applicant Rank Disclosure With Vitreoretinal Fellowship Applicant's Final Match Outcome in 2016 and 2017Steven M Christiansen, James M Osher, Christopher D RiemannJournal of Cataract and Refractive Surgery|October 3, 2006
Fate of anterior capsule tears during cataract surgeryFrederico F Marques, Daniela M V Marques, Robert H Osher, et al.Journal of Cataract and Refractive Surgery|September 3, 2004
Early uncorrected visual acuity as a measurement of the visual outcomes of contemporary cataract surgeryRobert H Osher, Marcílio G Barros, Daniela M V Marques, et al.Clinical Ophthalmology (Auckland, N.Z.)|October 5, 2016
Intravitreal methotrexate infusion for proliferative vitreoretinopathyAma Sadaka, Robert A Sisk, James M Osher, et al.Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|September 21, 2013
Pipeline embolization device: a new source for embolic retinal vascular occlusionAdam B Sise, James M Osher, Martin P Kolsky, et al.Retinal Cases & Brief Reports|April 16, 2019
COMBINED PHACOEMULSIFICATION SURGERY WITH MULTIFOCAL INTRAOCULAR LENS IMPLANTATION AND PARS PLANA VITRECTOMY FOR SYMPTOMATIC VITREOUS OPACITIESSunny B Patel, Michael E Snyder, Christopher D Riemann, et al.Clinical Ophthalmology (Auckland, N.Z.)|March 24, 2021
Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular TelangiectasiaTyler A Berger, Matthew W Manry, Lucas B Lindsell, et al.Pageof 2